Most Recent

image: Commander of an Immune Flotilla

Commander of an Immune Flotilla

By | April 1, 2014

With much of his early career dictated by US Navy interests, Carl June drew inspiration from malaria, bone marrow transplantation, and HIV in his roundabout path to a breakthrough in cancer immunotherapy.

1 Comment

image: Contributors

Contributors

By | April 1, 2014

Meet some of the people featured in the April 2014 issue of The Scientist.

0 Comments

image: Elusive Receptor ID’d

Elusive Receptor ID’d

By | April 1, 2014

Scientists identify an extracellular ATP receptor in plants.

0 Comments

image: Fighting Cancer with Nanomedicine

Fighting Cancer with Nanomedicine

By | April 1, 2014

Nanotechnology-based therapeutics will revolutionize cancer treatment.

2 Comments

image: Future Minded

Future Minded

By | April 1, 2014

Imagine consciousness traveling at the speed of light.

2 Comments

image: Going Long

Going Long

By | April 1, 2014

Researchers discover a tool to trigger an uncommon strategy cancer cells can use to lengthen their telomeres.

0 Comments

image: Maria Spies: Molecular Machinist

Maria Spies: Molecular Machinist

By | April 1, 2014

Associate Professor, Biochemistry, University of Iowa, Age: 40

0 Comments

image: Molecular Multitasker

Molecular Multitasker

By | April 1, 2014

Scientists create a way to isolate mRNA from a single living cell within a tissue.

0 Comments

image: Search and Destroy

Search and Destroy

By | April 1, 2014

Turning a patient’s immune cells into cancer-fighting weapons

0 Comments

image: Speaking of Science

Speaking of Science

By | April 1, 2014

April 2014's selection of notable quotes

2 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham